期刊文献+

表面活性蛋白A及D在小鼠尿路感染中的作用及机制 被引量:4

Innate immunity of surfactant protein A and D in urinary tract infection with uropathogenic Escherichia coli
原文传递
导出
摘要 目的研究表面活性蛋白(SP)A及sP—D在尿路感染(UTI)中的作用和机制,评价sP—A及SP—D缺失对UTI的影响。方法免疫组化评估sP—A及sP—D在野生型(wT)C57BL/6雌性小鼠肾脏内的表达及分布;Western印迹评价SP-A及sP—D双重敲除(SP—A/DKO)与wT小鼠肾脏p38磷酸化水平。应用SP-A/DKO小鼠和wT雌性小鼠构建逆行性小鼠UTI模型,小鼠分为2组:SP—A/DKO+UTI组和wT+UTI组,分别实验24h和48h。进行细菌培养及计数各组肾脏及尿液中的细菌含量,HE染色评价各组病理改变;免疫组化及计数肾脏及尿液内中性粒细胞的数量。体外细菌培养观察sP—A及sP—D对致尿路感染大肠杆菌(UPEC)生长的影响。结果wT小鼠肾脏内sP—A及SP—D主要分布于近曲小管及集合管。SP—A/DKO小鼠肾脏内p38磷酸化水平显著高于wT小鼠(P〈0.05)。SP—A/DKO小鼠在发生UTI时,其肾脏病理改变更重,中性粒细胞浸润更多。SP—A/DKO小鼠肾脏内及尿液内细菌量在24h及48h均显著高于wT小鼠(均P〈0.01)。体外实验显示,sP—A及sP—D均可显著抑制UPEC的生长(均P〈0.05)。结论肾脏内表达sP—A及SP—D;SP—A/DKO小鼠与wT小鼠相比,其对UTI更易感,其机制可能与UTI时炎性因子分泌不足及sP—A和sP—D对致尿路感染大肠杆菌生长的直接抑制有关。 Objective To investigate the role of surfactant protein (SP)- A and SP- D in urinary tract infection mouse model, and evaluate the effects of SP-A and SP- D absence on urinary tract infection. Methods SP-A and SP-D double knockout (SP-A/D KO) mice were made. SP-A/D KO and wild-type (WT) C57BL/6 female mice were used for this study. The expression of SP-A and SP-D in kidney was detected by immunohistochemistry (IHC). The levels of p-p38 and p38 protein in kidneys were measured by Western blotting. Uropathogenic Escherichia coli or buffer was delivered into the bladder of female mice. At 24 and 48 h after inoculation, CFU of Escherichia coli in the kidney and urine of the treated and control mice were measured. Histological, cellular and molecular analysis were performed by several methods of H/E staining, IHC and Western blotting. The effects of SP-A and SP-D on bacterial growth were studied in vitro. Results SP-A and SP-D in kidney were located in the proximal tubules and collecting tubules. Compared with WT mice, infected SP- A/D KO mice with UPEC had higher CFU in kidneys and urine at 24 h and 48 h, increased inflammatory cells infiltrationin kidneys (P〈0.05). Compared with WT mice, SP- A/D KO mice had higher p38 MAPK phosphorylation levels in kidneys (P 〈 0.05 ). Growth of Escherichia coli was greatly inhibited by both SP-A and SP-D (P 〈 0.05 ). Conclusions Both SP-A and SP-D are expressed in kidney. SP-A and SP-D can attenuate UTI induced by UPEC which may be through inhibiting bacterial growth and modulating renal inflammation.
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2013年第6期439-443,共5页 Chinese Journal of Nephrology
基金 国家自然科学基金(30670985.81070556)
关键词 表面活性蛋白A 表面活性蛋白D 尿路感染 天然免疫 Surfactant protein A Surfactant protein D Urinary tract infection Innateimmunity
  • 相关文献

参考文献12

  • 1Ben Mkaddem S, Chassin C, Vewalle A. Contribution of renal tubule epithelial cells in the innate immune response during renal bacterial infections and ischemia- reperfusion injury. Chang Gung Med J, 2010, 33: 225-240.
  • 2Hu F, Liang W, Ren Z, et al. Surfaetant protein D inhibits lipopolysaccharide-induced monocyte chemoattractant protein-1 expression in human renal tubular epithelial cells: implication for tubulointerstitial fibrosis. Clin Exp Immunol, 2012, 167: 514-522.
  • 3刘娇,梁伟,丁国华,王桂荣.表面活性蛋白A基因单核苷酸多态性与成年女性尿路感染易感性的关系[J].中华肾脏病杂志,2009,25(12):943-945. 被引量:3
  • 4Hung CS, Dodson KW, Hultgren SJ. A murine model of urinary tract infection. Nat Protoc, 2009, 4: 1230-1243.
  • 5吕金雷,丁国华.天然免疫分子在肾脏炎性反应及间质纤维化中的作用[J].中华肾脏病杂志,2007,23(10):685-688. 被引量:9
  • 6Zasloff M. Antimicrobial peptides, innate immunity, and the normally sterile urinary tract. J Am Soc Nephrol, 2007, 18: 2810-2816.
  • 7Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol, 2005, 5: 58-68.
  • 8Gardai SJ, Xiao YQ, Dickinson M, et al. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell, 2003, 115: 13-23.
  • 9Hawgood S, Ochs M, Jung A, et al. Sequential targeted deficiency of SP- A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol, 2002, 283: L1002-LIO10.
  • 10Lemos MP, McKinney J, Rhee KY. Dispensability of surfactant proteins A and D in immune control of Mycobacterium tuberculosis infection following aerosol challenge of mice. Infect Immun, 2011, 79: 1077-1085.

二级参考文献44

  • 1田少江,丁国华,王桂荣,桂元.表面活性蛋白A在大鼠急性肾盂肾炎动物模型中的表达[J].中华肾脏病杂志,2005,21(8):469-472. 被引量:9
  • 2田少江,丁国华,陈铖,贾俊亚,梁伟.表面活性蛋白A调节肾小管上皮细胞巨噬细胞炎症蛋白2的表达及其机制的探讨[J].中华肾脏病杂志,2006,22(5):303-306. 被引量:1
  • 3Chowdhury P, Sacks SH, Sheenin NS. Minireview: functionsof the renal tract epithelium in coordinating the innate immune response to infection. Kidney Int, 2004, 66: 1334- 1344.
  • 4Selman M, Lin HM, Montano N, et al. Surfactant protein A and B genetic variances predispose to idiopathic pulmonary fibrosis. Hum Genet, 2003, 113: 542-550.
  • 5Kankavi O. lmmunodetection of surfactant proteins in human organ of Corti, Eustachian tube and kidkey. Acta Biochim Pol, 2003, 50: 1057-1064.
  • 6MacNeill C, Umstead TM, Phelps DS, et al. Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid. Immunology, 2004, 111 : 91-99.
  • 7Pantelidis P, Lagan AL, Davies JC, et al. A single round PCR method for genotyping human surfactant protein (SP)- A1, SP-A2 and SP-D gene alleles. Tissue Antigens, 2003, 61: 317-321.
  • 8DiAngelo S, Lin Z, Wang G, et al. Novel, Non-Radioactive, simple and multiplex PCR-cRFLP methods for genotyping human SP-A and SP-D marker alleles. Dis Markers, 1999, 15: 269-281.
  • 9Vaid M, Kaur S, Sambatakou H, et al. Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic eavitary pulmonary aspergillosis and allergic bronehopulmonary aspergillosis. Clin Chem Lab Med, 2007, 45: 183-186.
  • 10Wang G, Phelps DS, Umstead TM, et al. Human SP-A protein variants derived from one or both genes stimulate TNF-α production in the THP-1 cell line. Am J Physiol Lung Cell Mol Physiol, 2000, 278: L946-L954.

共引文献9

同被引文献37

  • 1田少江,丁国华,王桂荣,桂元.表面活性蛋白A在大鼠急性肾盂肾炎动物模型中的表达[J].中华肾脏病杂志,2005,21(8):469-472. 被引量:9
  • 2吕金雷,丁国华.天然免疫分子在肾脏炎性反应及间质纤维化中的作用[J].中华肾脏病杂志,2007,23(10):685-688. 被引量:9
  • 3Foxman B.Urinary tract infection syndromes:occurrence,recurrence,bacteriology,risk factors,and disease burden[J].Infect Dis Clin North Am,2014,28:1-13.
  • 4Ulett GC,Totsika M,Schaale K,et al.Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection[J].Curr Opin Microbiol,2013,16:100-107.
  • 5Bates JM,Raffi HM,Prasadan K,et al.Tamm-Horsfall protein knockout mice are more prone to urinary tract infection:rapid communication[J].Kidney Int,2004,65:791-797.
  • 6Saemann MD,Weichhart T,Zeyda M,et al.Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism[J].J Clin Invest,2005,115:468-475.
  • 7Tittel AP,Heuser C,Ohliger C,et al.Kidney dendritic cells induce innate immunity against bacterial pyelonephritis[J].J Am Soc Nephrol,2011,22:1435-1441.
  • 8Schilling JD,Martin SM,Hunstad DA,et al.CD14-and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli[J].Infect Immun,2003,71:1470-1480.
  • 9Ashkar AA,Mossman KL,Coombes BK,et al.FimH adhesin of type 1 fimbriae is a potent inducer of innate antimicrobial responses which requires TLR4 and type 1 interferon signalling[J].PLoS Pathog,2008,4:e1000233.
  • 10Poltorak A,He X,Smirnova I,et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice:mutations in Tlr4 gene[J].Science,1998,282:2085-2088.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部